How has been the historical performance of the Sequent Scien.?

Answer:The historical performance of Sequent Scien. shows a fluctuating trend in net sales and profitability over the years, with a notable recovery in the most recent fiscal year.

Breakdown:
Sequent Scien. reported net sales of 1,551.37 Cr for the year ending March 2025, an increase from 1,369.73 Cr in March 2024 and 1,420.91 Cr in March 2023. The total operating income followed a similar trend, reaching 1,551.37 Cr in March 2025. However, the company faced challenges with raw material costs, which slightly increased to 617.37 Cr in March 2025 from 613.67 Cr in March 2024, while employee costs rose to 281.12 Cr. The total expenditure, excluding depreciation, was 1,389.58 Cr in March 2025, up from 1,308.32 Cr in the previous year. Operating profit (PBDIT) improved significantly to 176.48 Cr in March 2025, compared to 72.37 Cr in March 2024, indicating a recovery from the previous years' struggles. The profit before tax also turned positive at 44.31 Cr in March 2025, after two years of losses, leading to a profit after tax of 32.26 Cr, a significant turnaround from the losses of -29.62 Cr in March 2024 and -121.98 Cr in March 2023. The earnings per share (EPS) reflected this recovery, rising to 0.87 in March 2025 from -1.44 in March 2024. Overall, the financial metrics indicate a positive trend for Sequent Scien. in the latest fiscal year, suggesting a potential stabilization and growth phase.